The pharmaceutical landscape has been forever changed by the recent pandemic, and this is reflected in the growing importance of your go-to-market strategies.
Pharma companies are expanding into new and more specialised therapy areas, whilst simultaneously facing greater competition for their customer’s preferences and loyalty. To stand out from the crowd, your organisation requires greater understanding of your value proposition and underlying customer’s needs.
It’s also something we’re well-versed in at PEN.
In December, PEN held an interactive webinar. Jamie Campbell of PEN Partnership was joined by Peter Plöger, Country Managing Director of Boehringer Ingelheim Spain, and Ed Hollywood, General Manager at Boehringer Ingelheim France, to discuss the intricate details of getting your go-to-market strategy just right.
They covered several areas including:
- What are the key trends in go-to-market and customer engagement?
- The various challenges you’ll face, and the different approaches you can take to go-to-market models for Primary care, Specialty and Rare disease markets.
- What does your future go-to-market Strategy look like?
Whether you’re working within the life sciences sector or another industry, there was plenty of inspiration to draw from this webinar, with invaluable insights and expert guidance.
How we can help YOUR organisation’s GTM strategy
Does your Go-To-Market and Customer Engagement strategy need future proofing?
Take advantage of a free discovery workshop, led by PEN Partnership, where we can together explore your specific challenges, share tried and tested innovative engagement solutions and discuss how to apply them to make your Go-To-Market model future ready.
Please click here to request a workshop follow up!
Want to discover more about what's happening in the world of Life Sciences? Sign up for our newsletter and podcast Second Opinion and get the latest in your inbox and on your preferred podcast channels every month.